1 / 4

Basis for a pro-active Integration in Czech & Slovak Republic

Staying the Course. Basis for a pro-active Integration in Czech & Slovak Republic. Commitment to deliver 2009 results and to enhance significantly earnings in 2010. Management Meeting Czech & Slovak Republics. Solvay Pharma s.r.o. Personal presentation. CV within pharma industry in brief

mahlah
Télécharger la présentation

Basis for a pro-active Integration in Czech & Slovak Republic

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Staying the Course Basis for a pro-active Integration in Czech & Slovak Republic Commitment to deliver 2009 results and to enhance significantly earnings in 2010.Management Meeting Czech & Slovak Republics

  2. Solvay Pharma s.r.o.Personal presentation CV within pharma industry in brief • 2006 – now: Medical Manager Solvay pharma – Responsible for medical and governmental affairs • 2004 – 2005: European study manager – working on two GSK international R & D projects in oncology – small molecules and growth factors – in 11 resp. 5 countries in EU with links to US......... • 2002 – 2004: Lead Medical Director for CEE region at GlaxoSmitkline s.r.o. • 1991 – 2004: Medical Director Glaxo Smitkline s.r.o., before GlaxoWellcome s.r.o. and formerly Glaxo s.r.o., Czech Republic, Prague. 1991 – 1995 also responsible for medical affairs in GlaxoWellcome Slovakia.. Nota if needed…

  3. Solvay Pharma s.r.o.Personal achievement in current position • 2008 introduction new Solvay product – orphan drug therapy in neurology – Parkinson´s disease in 3 specialised centres in Czech Republic including full reimbursement • 2008 and 2009 gain significant number of new patients treated on Duodopa (21) • 2009 maintenance of current flu vaccine reimbursement in difficult time and government pressure on reimbursement. • 2007 and 2009 successful audits • 2009 – maintain current level of reimbursement for all the year Nota if needed…

  4. Solvay Pharma s.r.o.Current situation 2006 – now: Medical Manager Solvay Pharma – Responsible for • Medical (legal, ethical and medical issues) • This includes also medical training, drug safety, phase 4 clinical trials and audits • Governmental affairs (categorisation and pricing negotiations) • This includes as well close contacts with pricing and reimbursement authorities • The situation in forecasting Czech Healthcare System behaviour is on the background of the crisis quie unpredictable – the only constants are future cuts in the healthcare fundings Nota if needed…

More Related